Synergistic effects of chronic exposure to subthreshold concentrations of quinolinic acid and malonate in the rat striatum

Brain Research

Volumn 718, Issue 1-2, 1996, Pages 228-232

  Bazzett, Terence J ^a,b   Falik, Robert C ^b   Becker, Jill B ^a,b   Albin, Roger L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Basal ganglia; Chronic administration; Excitotoxicity; Huntington's disease; Mitochondria; Nitrix oxide synthase; NMDA

Indexed keywords

DIZOCILPINE; EXCITOTOXIN; MALONIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HISTOLOGY; HUNTINGTON CHOREA; MALE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030005568     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00143-6     Document Type: Article

References (27)

1. Albin, R.L. and Greenamyre, J.T., Alternative excitotoxic hypothesis, Neurology, 42 (1992) 733-738.
2. Bazzett, T.J., Falik, R.C., Becker, J.B. and Albin R.L., Chronic administration of malonic acid produces selective neural degeneration and transient changes in calbindin immunoreactivity in rat striatum, Exp. Neurol., 134 (1995) 1-10.
3. Bazzett, T.J., Falik, R.C., Becker, J.B. and Albin, R.L., Chronic intrastriatal administration of quinolinic acid produces transient nocturnal hypermotility in the rat, Brain Res. Bull., 39 (1996) 69-73.
4. Bazzett, T.J., Becker, J.B., Kaatz, K.W. and Albin, R.L., Chronic intrastriatal dialytic administration of quinolinic acid produces selective neural degeneration, Exp. Neurol., 120 (1993) 177-185.
5. Bazzett, T.J., Becker J.B. and Albin R.L., A novel device for chronic intracranial drug delivery via microdialysis, J. Neurosci. Methods, 40 (1991) 1-8.
6. Bazzett, T.J., Becker, J.B. and Albin, R.L., Construction and implantation of a chronic intracranial dialytic delivery system, Neurosci. Prot., 6 (1994) 1-10.
7. Beal, M.F., Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol., 31 (1992) 119-130.
8. Beal, M.F., Aging, energy, and oxidative stress in neurodegenerative disease, Ann. Neurol., 38 (1995) 357-366.
9. Beal, M.F., Brouilet, E., Jenkins, B.G., Henshaw, R., Rosen, B. and Hyman, B.T., Age-dependent striatal excitotoxic lesions produced by the endogenous mitochondrial inhibitor malonate, J. Neurochem., 61 (1993) 1147-1150.
10. Beal, M.F., Ferrante, R.J., Swartz, K.J. and Kowall, N.W., Chronic quinolinic acid lesions in rats closely resemble Huntington's disease, J. Neurosci., 11 (1991) 1649-1659.
11. Beal, M.F., Kowall, K.W., Ellison, D.W., Mazurek, M.F., Swartz, K.J. and Martin, J.B., Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid, Nature, 321 (1986) 168-171.
12. Beal, M.F., Kowall, N.W., Swartz, K.J., Ferrante, R.J. and Martin, J.B., Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions, Synapse, 3 (1989) 38-47.
13. Boegman, R.J. and Parent, A., Differential sensitivity of neuropeptide Y, somatostatin and NADPH-diaphorase containing neurons in rat cortex and striatum to quinolinic acid, Brain Res., 445 (1988) 358-362.
14. Boegman, R.J., Smith, Y. and Parent A., Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons, Brain Res., 415 (1987) 178-182.
15. Davies, S.W. and Roberts, P.J., Sparing of cholinergic neurons following quinolinic acid lesions of the rat striatum, Neuroscience, 26 (1988) 387-393.
16. Ferrante, R.J., Kowall, N.W., Beal, M.F., Richardson, E.P., Bird, E.D. and Martin, J.B., Selective sparing of a class of striatal neurons in Huntington's disease, Science, 230 (1985) 561-564.
17. Greene, J.G. and Greenamyre, J.T., Exacerbation of NMDA, AMPA and L-Glutamate excitotoxicity by the succinate dehydrogenase inhibitor maloante, J. Neurochem., 64 (1995) 2332-2338.
18. Greene, J.G., Porter, R.H.P., Eller, R.V. and Greenamyre, J.T., Inhibition of succinate dehydrogenase by malonic acid produces an 'excitotoxic' lesion in rat striatum, J. Neurochem., 61 (1993) 1151-1154.
19. Henshaw, R., Jenkins, B.G., Shultz, J.B., Ferrante, R.J., Kowall, N.W., Rosen, B.R. and Beal, M.F., Malonate produces striatal lesions by indirect NMDA receptor activation, Brain Res., 647 (1994) 161-166.
20. 1H NMR spectroscopy, Neurology, 43 (1993) 2689-2695.
21. Mackenzie, G.M., Jenner, P. and Marsden C.D., The effect of nitric oxide synthase inhibition on quinolinic acid toxicity in the rat striatum, Neuroscience, 67 (1995) 357-371.
22. Mazziotta, J.C., Phelps, M.E., Pahl, J.J., Huang, S.C., Baxter, L.R., Riege, W.H., Hoffman, J.M., Kuhl, D.E., Lanto, A.B., Wapenski, J.A. and Markham, C.H., Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease, N. Engl. J. Med., 316 (1987) 357-362.
23. Reynolds, G.P., Pearson, S.J., Halket, J. and Sarellar, M., Brain quinolinic acid in Huntingtion's disease, J. Neurochem., 50 (1988) 1959-1960.
24. Roberts, R.C. and DiFiglia, M., Localization of immunoreactive GABA and enkephalin and NADPH-diaphorase-positive neurons in fetal striatal grafts in the quinolinic-acid-lesioned rat neostriatum, J. Comp Neurol., 274 (1988) 406-421.
25. Schwarcz, R., Tamminga, C.A., Kurlan, R. and Shoulson, I., Cerebrospinal fluid levels of quinolinic acid in Huntington's disease and schizophrenia, Ann. Neurol., 24 (1988), 580-582.
26. Wong-Riley, M.T.T., Cytochrome oxidase: an endogenous metabolic marker for neuronal activity, TINS, 12 (1989) 94-101.
27. Young, A.B., Penny, J.B., Sarosta-Rubinstein, S., Markel, D., Berent, S., Rothley, J., Betley, A. and Hichwa, R., Normal caudate glucose metabolism in persons at risk for Huntington's disease, Arch. Neurol., 44 (1987) 254-257.